levofloxacin has been researched along with galangin in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (galangin) | Trials (galangin) | Recent Studies (post-2010) (galangin) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 366 | 0 | 238 |
| Protein | Taxonomy | levofloxacin (IC50) | galangin (IC50) |
|---|---|---|---|
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 35.5 | |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 8.56 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 9 | |
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.077 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.04 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.13 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.65 | |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 1.8 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.014 | |
| Aurora kinase B | Homo sapiens (human) | 9.8 | |
| Short transient receptor potential channel 5 | Homo sapiens (human) | 0.45 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalra, S; Khatik, GL; Kumar, GN; Kumar, R; Narang, R; Nayak, SK; Singh, SK; Sudhakar, K | 1 |
1 review(s) available for levofloxacin and galangin
| Article | Year |
|---|---|
Recent advancements in mechanistic studies and structure activity relationship of F
Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Proton-Translocating ATPases; Structure-Activity Relationship | 2019 |